TSPAN32 and myeloid sarcoma: More interestingly, pathogenetic T cells from EAE mice express lower transcriptional levels of TSPAN32 and, following stimulation, T helper cells from MS patients have significantly lower mRNA levels of TSPAN32 than cells from healthy controls [8].